返回 Agendas
Recent Trends in Facilitating Decision Making in Drug Development
Session Chair(s)
Akhil Agrawal, MD, PMP
Associate Director
Bristol-Myers Squibb Company, United States
This forum will focus on sharing best practices on facilitating decision making while adapting to recent industry trends which impact R&D projects. Presentations including case studies will be provided followed by an open forum discussion.
Learning Objective : Discuss recent industry trends such as the changing health care environment, increased empowerment of development teams, and increased emphasis on return on investment; Within the context of the recent industry trends, explain how to facilitate decision making in drug development projects.
Speaker(s)
Decision-Making in Early Development: Large and Small Pharma Perspectives
Erin Tynebor, MBA, MS
Merck & Co., Inc., United States
Director, M&A Integration, Regulatory Affairs
Effective Decision-Making in Late-Stage Drug Development
Cary McConlogue, PhD, MBA
Bristol-Myers Squibb Company, United States
Group Director, Biopharma Project Management
Enhancing Your Influence in Project and Portfolio Decision Making
Jennifer Ikeda, MBA, PMP
Acuity Advantage Consulting, LLC, United States
Principal
注册方法
Registration override should work.